SO ENDS this remarkable paper that talks about the transition from bench to bedside in the genomics world, and how it applies especially to personalized medicine. Look at Arivale Inc by Leroy Hood or Craig Venter’s Longevity Inc as commercial efforts in this exciting sector.
https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022